Matching slides 24,547
Current window 16,561-16,590
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

16,561-16,590 of 24,547

filter-aware
27
The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies, emphasizing non-GMO status and GLP tox readiness.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
The slide highlights key defensive moats including patent counts, expiration dates, and lack of royalty obligations.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
38
The slide uses clinical study data (VIRO-15, NCT01443260) to support its claims.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a process flow diagram to illustrate the user journey and system architecture.HeartBeam | Investor Presentation Deck | 18 slides · HeartBeam
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Includes a comparison visual between the compact device and a traditional hospital ECG setup.HeartBeam | Investor Presentation Deck | 18 slides · HeartBeam
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide showcases a range of hardware and software solutions, including the AIMIGo device, patches, watches, and deep learning analytics.HeartBeam | Investor Presentation Deck | 18 slides · HeartBeam
Pitch deck Investor relations 1 hit
11
Heartland Financial USA | Results Presentation Deck | 35 slidesHeartland Financial USA | Results Presentation Deck | 35 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Financial PerformanceLoop · Cost Of Inaction1 hit
06
HomeStreet | Results Presentation Deck | 36 slidesHomeStreet | Results Presentation Deck | 36 slides · HomeStreet
Conference presentation Investor relations Beat · Need1 hit
21
Slide 21 of a pitch deck.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Competition1 hit
05
Includes a cartoon mascot at the bottom.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide highlights the structural difference of the NXC-201 molecule compared to Abecma, Carvykti, and CART-ddBCMA.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
09
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
19
The slide uses a side-by-side comparison structure to explain two distinct but complementary technology platforms.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · VisualizationLoop · Why Now1 hit
33
Includes scientific diagrams of molecular pathways and efficacy data charts.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
43
The slide uses a process-flow layout to connect platform capabilities to specific product outputs.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
44
The slide uses a '3 Pillars' framework to explain the platform foundation, followed by a product-specific breakdown.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
45
Includes technical diagrams of the drug delivery mechanism and comparative survival data.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
47
Includes detailed scientific diagrams of the drug mechanism and clinical trial results.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Satisfaction1 hit
10
Uses a three-part narrative structure: market decline vs. company growth vs. improved ranking.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations Beat · KPI Overview1 hit
17
The slide uses a three-column layout to explain the partnership, the benefits, and the specific client coverage model.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
20
Jefferies Financial Group | Investor Presentation Deck | 74 slidesJefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
49
The slide uses a visual representation of TAM expansion (Current vs. Expanded) to support the second strategic pillar.Jefferies Financial Group | Investor Presentation Deck | 74 slides · Jefferies
Conference presentation Investor relations 1 hit
08
Uses a before-after framework to illustrate strategic evolution.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Logic Chain1 hit
05
Kering | Investor Presentation Deck | 62 slidesKering | Investor Presentation Deck | 62 slides · Kering
Conference presentation Investor relations Beat · Problem1 hit
08
Uses a before-after framing to justify a shift in strategic focus for luxury houses.Kering | Investor Presentation Deck | 62 slides · Kering
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
10
Kering | Investor Presentation Deck | 62 slidesKering | Investor Presentation Deck | 62 slides · Kering
Conference presentation Investor relations Beat · Solution1 hit
31
Includes a visual comparison of land impact vs. restoration commitment.Kering | Investor Presentation Deck | 62 slides · Kering
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
32
Kering | Investor Presentation Deck | 62 slidesKering | Investor Presentation Deck | 62 slides · Kering
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a central circle to emphasize 'Established Global Leadership & Diversification' as the unifying theme between the two business units.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · Market Size1 hit
09
Lazard | Investor Presentation Deck | 46 slidesLazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · Business ModelLoop · Why Now1 hit